WHO ICTRP trial
Comparison the Effect of Quetiapine and Haloperidol on the Treatment of…
IRCT20180911040998N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20180911040998N1 |
|---|---|
| Public title | Comparison the Effect of Quetiapine and Haloperidol on the Treatment of ?delirium in ICU |
| Scientific title | Comparison the Effect of Quetiapine and Haloperidol on the Treatment of ?delirium in ICU |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | delirium. Delirium due to known physiological condition |
| Interventions | Intervention 1: Intervention group1: We inject 2.5 milligram in day Haloperidol in first group. Intervention 2: Intervention group2: We inject 25 milligram Quetiapine twice in day in second group. |
| Registration date | Oct 31, 2018 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: